GeneDx Holdings EBITDA Margin 2020-2024 | WGS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for GeneDx Holdings (WGS) over the last 10 years. The current EBITDA margin for GeneDx Holdings as of March 31, 2024 is .
| GeneDx Holdings EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-03-31 | $0.22B | $-0.10B | -46.61% |
| 2023-12-31 | $0.20B | $-0.15B | -72.77% |
| 2023-09-30 | $0.21B | $-0.42B | -202.91% |
| 2023-06-30 | $0.24B | $-0.46B | -196.61% |
| 2023-03-31 | $0.22B | $-0.58B | -258.74% |
| 2022-12-31 | $0.23B | $-0.61B | -259.83% |
| 2022-09-30 | $0.23B | $-0.43B | -184.85% |
| 2022-06-30 | $0.19B | $-0.43B | -225.13% |
| 2022-03-31 | $0.20B | $-0.32B | -156.44% |
| 2021-12-31 | $0.21B | $-0.43B | -200.47% |
| 2021-06-30 | $0.15B | $-0.29B | -192.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.696B | $0.203B |
| GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.523B | 15.62 |
| Cencora (COR) | United States | $45.467B | 17.73 |
| ICON (ICLR) | Ireland | $25.839B | 24.39 |
| DiDi Global (DIDIY) | China | $20.560B | 0.00 |
| Avantor (AVTR) | United States | $14.550B | 21.42 |
| CochLear (CHEOY) | Australia | $14.235B | 0.00 |
| Natera (NTRA) | United States | $13.510B | 0.00 |
| Medpace Holdings (MEDP) | United States | $13.148B | 43.26 |
| Revvity (RVTY) | United States | $13.044B | 22.88 |
| Viatris (VTRS) | United States | $12.478B | 3.73 |
| Charles River Laboratories (CRL) | United States | $10.681B | 20.45 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.978B | 0.00 |
| Solventum (SOLV) | United States | $8.865B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.503B | 0.00 |
| HealthEquity (HQY) | United States | $7.335B | 47.10 |
| Organon (OGN) | United States | $5.295B | 5.02 |
| Bausch + Lomb (BLCO) | Canada | $5.197B | 20.80 |
| Doximity (DOCS) | United States | $5.160B | 36.14 |
| PACS (PACS) | United States | $4.601B | 0.00 |
| Life Times (LTH) | United States | $3.772B | 39.52 |
| Sotera Health (SHC) | United States | $3.369B | 16.53 |
| Surgery Partners (SGRY) | United States | $3.091B | 28.28 |
| GoodRx Holdings (GDRX) | United States | $2.885B | 109.86 |
| Progyny (PGNY) | United States | $2.725B | 46.92 |
| Agilon Health (AGL) | United States | $2.710B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.968B | 7.80 |
| Premier (PINC) | United States | $1.926B | 8.24 |
| NovoCure (NVCR) | Jersey | $1.897B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.854B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.720B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.501B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.207B | 0.00 | |
| CareDx (CDNA) | United States | $0.749B | 0.00 |
| Embecta (EMBC) | United States | $0.719B | 4.89 |
| InnovAge Holding (INNV) | United States | $0.713B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.608B | 6.45 |
| Auna S.A (AUNA) | Luxembourg | $0.594B | 0.00 |
| Sharecare (SHCR) | United States | $0.500B | 0.00 |
| Enhabit (EHAB) | United States | $0.430B | 42.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.410B | 0.00 |
| ModivCare (MODV) | United States | $0.359B | 6.71 |
| QDM (QDMI) | Hong Kong, SAR China | $0.353B | 9.24 |
| Sonida Senior Living (SNDA) | United States | $0.348B | 0.00 |
| DocGo (DCGO) | United States | $0.326B | 17.83 |
| LifeMD (LFMD) | United States | $0.279B | 0.00 |
| MultiPlan (MPLN) | United States | $0.272B | 0.00 |
| Beauty Health (SKIN) | United States | $0.235B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.208B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.187B | 0.00 |
| Biodesix (BDSX) | United States | $0.172B | 0.00 |
| So-Young (SY) | China | $0.108B | 52.00 |
| Pono Capital Two (PTWO) | United States | $0.070B | 0.00 |
| NeueHealth (NEUE) | United States | $0.043B | 5.78 |
| Co-Diagnostics (CODX) | United States | $0.040B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
| Oncology Institute (TOI) | United States | $0.033B | 0.00 |
| Nutex Health (NUTX) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.021B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.021B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.019B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.017B | 0.00 |
| KindlyMD (KDLY) | $0.017B | 0.00 | |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |